ACADIA Pharmaceuticals
ACAD
#3427
Rank
A$6.40 B
Marketcap
A$37.40
Share price
3.06%
Change (1 day)
17.43%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): A$0.21 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.07 Billion. a decrease over its 2024 earnings that were of A$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 A$0.20 B-46.18%
2024 A$0.37 B-605.67%
2023 -A$73.51 Million-76.09%
2022 -A$0.31 Billion27.41%
2021 -A$0.25 Billion-40.38%
2020 -A$0.41 Billion19.88%
2019 -A$0.34 Billion-3.92%
2018 -A$0.36 Billion-15.04%
2017 -A$0.42 Billion6.33%
2016 -A$0.39 Billion64.55%
2015 -A$0.24 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$54.66 Million81.93%
2012 -A$30.05 Million-8.73%
2011 -A$32.92 Million-251.39%
2010 A$21.74 M-133.2%
2009 -A$65.49 Million-30.82%
2008 -A$94.67 Million6.43%
2007 -A$88.95 Million25.89%
2006 -A$70.66 Million36.99%
2005 -A$51.58 Million37.22%
2004 -A$37.59 Million19.96%
2003 -A$31.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.41 B 18,602.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.25 B 7,524.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.82 B 22,307.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.82 B 6,809.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.18 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$55.64 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA